Board Meetings for GLAXO
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 25 Jul 2022 | Financial results | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 25-Jul-2022 to consider financial statements for the period ended June 2022 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 16 May 2022 | Dividend/Financial results | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 16-May-2022 to consider financial statements for the period ended March 2022 and Dividend | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 07 Feb 2022 | Financial Results | To consider and approve the financial results for the period ended December 31, 2021 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 29 Oct 2021 | Financial Results | To consider and approve the financial results for the period ended September 30, 2021 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 26 Jul 2021 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 18 May 2021 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 05 Feb 2021 | Financial Results | To consider and approve the financial results for the period ended December 31, 2020 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 28 Oct 2020 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 29 Jul 2020 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 18 May 2020 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend if any | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 03 Feb 2020 | Financial Results | To consider and approve the financial results for the period ended December 31, 2019 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 22 Oct 2019 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2019 and other business matters | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 22 Jul 2019 | Financial Results | Pursuant to clause 33 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), this is to inform you that a meeting of the Board of Directors of our Company will be held on Monday, 22nd July 2019, inter-alia, to consider approval of Un-audited financial results for the first quarter ended 30th June 2019. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 20 May 2019 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend and other business matters | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 04 Feb 2019 | Financial Results | to consider approval and declaration of Un-Audited Financial Results for the quarter and nine months ended December 31, 2018. |